Anti-Tumor Necrosis Factor Soluble Receptor Type II antibody produced in goat

MFCD01633483

NA.41

TNF RII is a type I transmembrane glycoprotein primarily expressed on hematopoietic cells and is designated TNFRSF1B. TNF RII is a highaffinity receptor for TNF alpha and TNF beta. A soluble form of the receptor generated by proteolytic cleavage functions as a TNF antagonist.

The antibody detects human TNF sRII and shows no cross-reactivity with recombinant human TNF sRI.

recombinant human TNF soluble receptor II (TNF sRII) expressed in Escherichia coli. The immunogen is the non-glycosylated, N-terminal methionyl form of the naturally-occurring human soluble type II receptor for TNF, minus 53 amino acids from the proline-rich region just exterior to the transmembrane domain.

Western Blot: 1 ug/mL detects rhs TNF RII at 5 ng/lane under non-reducing conditions
Immunocytochemistry: Concentration of 5-15 ug/ml detects TNF RII in human peripheral blood lymphocytes

Optimal dilutions should be determined by the end user.

Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline (pH 7.4) and 5% trehalose.

Protein A or G purified

200

goat

unconjugated

IgG fraction of antiserum

primary antibodies

polyclonal

lyophilized powder

human

immunocytochemistry: 5-15 μg/mL (detects TNF RII in human PBLs)
western blot: 1 μg/mL (detects rhs TNF RII at 5 ng/lane under non-reducing conditions)

P20333

−20℃

human ... TNFRSF1B(7133)

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

13 - Non Combustible Solids

WGK 1